Brief: Sophia Genetics Enters Collaboration To Develop Companion Diagnostics For Precision Oncology Therapies
04/08/2026 11:49
BRIEF-Sophia Genetics Enters Collaboration To Develop Companion Diagnostics For Precision Oncology Therapies Aug 4 (Reuters) - Sophia Genetics SA 90B.F:
SOPHIA GENETICS ENTERS COLLABORATION TO DEVELOP COMPANION DIAGNOSTICS FOR PRECISION ONCOLOGY THERAPIES
SOPHIA GENETICS - TO DEVELOP SOLID TUMOR APPLICATION AS DECENTRALIZED COMPANION DIAGNOSTIC
SOPHIA GENETICS : ENTERS MULTI-YEAR COLLABORATION WITH ASTRAZENECA ON TWO COMPANION DIAGNOSTICS
Source text: ID:nPreCPTmxa
Further company coverage: 90B.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sophia Genetics SA
See all newsSwitzerland's SOPHiA GENETICS Q2 revenue rises on Liquid Biopsy growth
Brief: Sophia Genetics Enters Collaboration To Develop Companion Diagnostics For Precision Oncology Therapies
Sophia Genetics dips on $50 mln stock sale
Brief: Sophia Genetics Announces Pricing Of $50 Million Public Offering Of Ordinary Shares
Brief: Sophia Genetics Announces Proposed Public Offering Of Ordinary Shares